Phase 1b/2 Study of TTI-101 in Combination for Patients With Metastatic Hormone Receptor-Positive and HER2-Negative Breast Cancer
Clinical trial NCT05384119 · TERMINATED
Trial details
- NCT number
- NCT05384119
- Sponsor
- Tvardi Therapeutics, Incorporated
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-09
- Primary completion
- 2024-04-25
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.